Enanta Pharmaceuticals Inc (ENTA)

[dewophile]

These are not small trials, and this is only one indication of many. they are in phase 2 in 3-4 other programs, probably to start phase 3 soon in CINDU (inducible urticaria), and the pipeline doesn't even mention asthma which is perhaps the largest indication but also costliest
So the bottom line is I think ENTA is going to have to partner this drug early on
CLDX has over 800M in cash